Our risk model derived from bioinformatic analysis needs to be further confirmed by functional and mechanistic experiments, as only three of the genes included in the signature, TYMP, PCNA, and WRN, have been previously studied as prognostic markers for DLBCL. Here, TYMP is linked to diffuse large B-cell lymphoma.